BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9988796)

  • 1. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women.
    Cicinelli E; Ignarro LJ; Matteo MG; Galantino P; Schonauer LM; Falco N
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):334-9. PubMed ID: 9988796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
    Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women.
    Cicinelli E; Ignarro LJ; Schönauer LM; Matteo MG; Galantino P; Balzano G
    Fertil Steril; 1998 Jan; 69(1):58-61. PubMed ID: 9457933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tibolone on plasma levels of nitric oxide in postmenopausal women.
    Cicinelli E; Ignarro LJ; Galantino P; Pinto V; Barba B; Schonauer S
    Fertil Steril; 2002 Sep; 78(3):464-8. PubMed ID: 12215318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women.
    Cicinelli E; Ignarro LJ; Lograno M; Matteo G; Falco N; Schonauer LM
    Fertil Steril; 1997 Jan; 67(1):63-6. PubMed ID: 8986685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study.
    Cagnacci A; Tarquini R; Perfetto F; Arangino S; Zanni AL; Cagnacci P; Facchinetti F; Volpe A
    Maturitas; 2003 Feb; 44(2):117-24. PubMed ID: 12590007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of estrogen replacement therapy on plasma nitric oxide levels in postmenopausal women].
    Ye Y; Dai S; Zhang S
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):340-1. PubMed ID: 10806670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels.
    Smolders RG; van der Mooren MJ; Teerlink T; Merkus JM; Kroeks MV; Franke HR; Stehouwer CD; Kenemans P
    Fertil Steril; 2003 Feb; 79(2):261-7. PubMed ID: 12568832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints.
    von Holst T; Salbach B
    Maturitas; 2000 Feb; 34(2):143-53. PubMed ID: 10714909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
    Lai A; Zhang J; Ding L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women.
    Piccinini F; Rovati L; Zanni A; Cagnacci A; Volpe A; Facchinetti F
    Gynecol Endocrinol; 2000 Apr; 14(2):142-6. PubMed ID: 10836202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women.
    Best PJ; Berger PB; Miller VM; Lerman A
    Ann Intern Med; 1998 Feb; 128(4):285-8. PubMed ID: 9471931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of sex hormones on serum levels of nitric oxide and plasma angiotensin II in postmenopausal women].
    Zheng X; He FF; Nie M; Sun ML; Ge QS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):635-8. PubMed ID: 12905695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In normal postmenopausal women physiologic estrogen replacement therapy fails to improve exercise tolerance: a randomized, double-blind, placebo-controlled, crossover trial.
    Snabes MC; Herd JA; Schuyler N; Dunn K; Spence DW; Young RL
    Am J Obstet Gynecol; 1996 Jul; 175(1):110-4. PubMed ID: 8694035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.
    Asthana S; Craft S; Baker LD; Raskind MA; Birnbaum RS; Lofgreen CP; Veith RC; Plymate SR
    Psychoneuroendocrinology; 1999 Aug; 24(6):657-77. PubMed ID: 10399774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
    Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. A randomized, double-blind, placebo-controlled, crossover study.
    Haines C; Chung T; Chang A; Masarei J; Tomlinson B; Wong E
    Arch Intern Med; 1996 Apr; 156(8):866-72. PubMed ID: 8774205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.